Infrared coagulator treatment of high-grade anal dysplasia in HIV-infected individuals: An AIDS Malignancy Consortium pilot study Journal Article


Authors: Stier, E. A.; Goldstone, S. E.; Berry, J. M.; Panther, L. A.; Jay, N.; Krown, S. E.; Lee, J.; Palefsky, J. M.
Article Title: Infrared coagulator treatment of high-grade anal dysplasia in HIV-infected individuals: An AIDS Malignancy Consortium pilot study
Abstract: OBJECTIVE: To evaluate prospectively the safety of the infrared coagulator (IRC) as a treatment for anal high-grade squamous intraepithelial lesions (HSILs) in HIV-infected individuals and to seek preliminary evidence for efficacy. METHODS: HIV-infected patients with ≤3 biopsy-proven internal anal HSILs received office-based treatment with the IRC at participating AIDS Malignancy Consortium sites. Treatments were performed during high-resolution anoscopy (HRA) under local anesthesia. Patients were reevaluated at 3 months, and persistent lesions could be retreated. Patients were evaluated every 3 months for a year with anal cytology and HRA with biopsy. Human papillomavirus (HPV) DNA was measured at baseline and at follow-up using MY09/MY11 L1 polymerase chain reaction. RESULTS: A total of 44 HSILs were treated from 16 men and 2 women. HPV 16 was the most common HPV type identified. There was no consistent change in HPV type or viral load in patients before and after treatment with the IRC. No procedure-related severe adverse events were reported. Twelve patients reported mild or moderate anal/rectal pain or bleeding. CONCLUSIONS: The IRC is a well-tolerated method of treating discrete anal canal HSILs in HIV-infected patients. A larger study to characterize its efficacy better in the management of HSILs in HIV-infected individuals is warranted. © 2008 Lippincott Williams & Wilkins, Inc.
Keywords: clinical article; controlled study; clinical trial; drug tolerability; drug efficacy; human immunodeficiency virus infection; follow up; prospective study; prospective studies; polymerase chain reaction; cytology; virology; pilot study; pilot projects; multicenter study; acquired immune deficiency syndrome; highly active antiretroviral therapy; virus load; antiretroviral therapy, highly active; hyperthermic therapy; isolation and purification; hiv infections; wart virus; rectum hemorrhage; precancerous conditions; papilloma virus; human immunodeficiency virus infected patient; local anesthesia; viral load; infrared radiation; precancer; rectum biopsy; anus neoplasms; anus tumor; papillomaviridae; anal dysplasia; hiv infection; human papilloma virus; anus disease; infrared coagulator therapy; phototherapy; infrared rays
Journal Title: JAIDS: Journal of Acquired Immune Deficiency Syndromes
Volume: 47
Issue: 1
ISSN: 1525-4135
Publisher: Lippincott Williams & Wilkins  
Date Published: 2008-01-01
Start Page: 56
End Page: 61
Language: English
DOI: 10.1097/QAI.0b013e3181582d93
PUBMED: 18156992
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 23" - "Export Date: 17 November 2011" - "CODEN: JJASF" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Elizabeth A Stier
    12 Stier
  2. Susan Krown
    156 Krown